Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) [Abstract]        
Revenue, net $ 646,141 $ 0 $ 1,168,308 $ 0
Cost of revenue 398,988 0 699,067 0
Gross profit 247,153 0 469,241 0
Operating expenses:        
Research and development 16,180 5,985 86,244 54,475
General and administrative 857,183 247,006 1,381,701 433,946
Total operating expenses 873,363 252,991 1,467,945 488,421
Loss from operations (626,210) (252,991) (998,704) (488,421)
Other expense:        
Interest expense 202,004 9,512 381,357 17,219
Total other expense 202,004 9,512 381,357 17,219
Net loss (828,214) (262,503) (1,380,061) (505,640)
Deemed dividend for warrant down round feature (32,588) 0 (32,588) 0
Net loss applicable to common stockholders $ (860,802) $ (262,503) $ (1,412,649) $ (505,640)
Net loss per common share - common stockholders - basic and diluted (in dollars per share) $ (0.02) $ (0.01) $ (0.04) $ (0.02)
Weighted average shares outstanding - basic and diluted (in shares) 40,074,375 29,967,824 39,012,842 29,868,277